{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T08:14:00Z","timestamp":1783152840118,"version":"3.54.6"},"reference-count":144,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,3,15]],"date-time":"2007-03-15T00:00:00Z","timestamp":1173916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,3,15]],"date-time":"2007-03-15T00:00:00Z","timestamp":1173916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cancer"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1038\/nrc2091","type":"journal-article","created":{"date-parts":[[2007,3,15]],"date-time":"2007-03-15T10:17:26Z","timestamp":1173953846000},"page":"233-245","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1213,"title":["The impact of translocations and gene fusions on cancer causation"],"prefix":"10.1038","volume":"7","author":[{"given":"Felix","family":"Mitelman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertil","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Mertens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,3,15]]},"reference":[{"key":"BFnrc2091_CR1","volume-title":"Zur Frage der Entstehung maligner Tumoren","author":"T Boveri","year":"1914","unstructured":"Boveri, T. Zur Frage der Entstehung maligner Tumoren. Gustav Fisher Verlag, Jena (1914)."},{"key":"BFnrc2091_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1601-5223.1956.tb03010.x","volume":"42","author":"JH Tjio","year":"1956","unstructured":"Tjio, J. H. & Levan, A. The chromosome number of man. Hereditas 42, 1\u20136 (1956).","journal-title":"Hereditas"},{"key":"BFnrc2091_CR3","first-page":"1497","volume":"132","author":"PC Nowell","year":"1960","unstructured":"Nowell, P. C. & Hungerford, D. A. A minute chromosome in human chronic granulocytic leukemia. Science 132, 1497 (1960). The first description of a specific cancer-associated chromosome abnormality.","journal-title":"Science"},{"key":"BFnrc2091_CR4","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0014-4827(70)90523-9","volume":"60","author":"T Caspersson","year":"1970","unstructured":"Caspersson, T., Zech, L. & Johansson, C. Differential binding of alkylating fluorochromes in human chromosomes. Exp. Cell. Res. 60, 315\u2013319 (1970).","journal-title":"Exp. Cell. Res."},{"key":"BFnrc2091_CR5","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/nm1087","volume":"10","author":"B Vogelstein","year":"2004","unstructured":"Vogelstein, B. & Kinzler, K. W. Cancer genes and the pathways they control. Nature Med. 10, 789\u2013799 (2004).","journal-title":"Nature Med."},{"key":"BFnrc2091_CR6","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/243290a0","volume":"243","author":"JD Rowley","year":"1973","unstructured":"Rowley, J. D. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243, 290\u2013293 (1973). The first report of a specific translocation in a human malignancy.","journal-title":"Nature"},{"key":"BFnrc2091_CR7","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/372143a0","volume":"372","author":"TH Rabbitts","year":"1994","unstructured":"Rabbitts, T. H. Chromosomal translocations in human cancer. Nature 372, 143\u2013149 (1994).","journal-title":"Nature"},{"key":"BFnrc2091_CR8","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1126\/science.278.5340.1059","volume":"278","author":"AT Look","year":"1997","unstructured":"Look, A. T. Oncogenic transcription factors in human acute leukemias. Science 278, 1059\u20131064 (1997).","journal-title":"Science"},{"key":"BFnrc2091_CR9","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/35106108","volume":"1","author":"JD Rowley","year":"2001","unstructured":"Rowley, J. D. Chromosomal translocations: dangerous liaisons revisited. Nature Rev. Cancer 1, 245\u2013250 (2001).","journal-title":"Nature Rev. Cancer"},{"key":"BFnrc2091_CR10","unstructured":"Mitelman, F., Johansson, B. & Mertens, F. Mitelman Database of Chromosome Aberrations in Cancer [online], http:\/\/cgap.nci.nih.gov\/Chromosomes\/Mitelman (2006). A comprehensive resource of all published neoplasia-associated karyotypes and their corresponding gene fusions."},{"key":"BFnrc2091_CR11","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s00412-005-0002-z","volume":"114","author":"L Kearney","year":"2005","unstructured":"Kearney, L. & Horsley, S. W. Molecular cytogenetics in haematological malignancy: current technology and future prospects. Chromosoma 114, 286\u2013294 (2005).","journal-title":"Chromosoma"},{"key":"BFnrc2091_CR12","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1038\/ng1569","volume":"37","author":"D Pinkel","year":"2005","unstructured":"Pinkel, D. & Albertson, D. G. Array comparative genomic hybridization and its applications in cancer. Nature Genet. 37, S11\u2013S17 (2005).","journal-title":"Nature Genet."},{"key":"BFnrc2091_CR13","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/nrg1692","volume":"6","author":"MR Speicher","year":"2005","unstructured":"Speicher, M. R. & Carter, N. P. The new cytogenetics: blurring the boundaries with molecular biology. Nature Rev. Genet. 6, 782\u2013792 (2005).","journal-title":"Nature Rev. Genet."},{"key":"BFnrc2091_CR14","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nrc1299","volume":"4","author":"PA Futreal","year":"2004","unstructured":"Futreal, P. A. et al. A census of human cancer genes. Nature Rev. Cancer 4, 177\u2013183 (2004).","journal-title":"Nature Rev. Cancer"},{"key":"BFnrc2091_CR15","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1126\/science.1133427","volume":"314","author":"T Sj\u00f6blom","year":"2006","unstructured":"Sj\u00f6blom, T. et al. The consensus coding sequences of human breast and colorectal cancers. Science 314, 268\u2013274 (2006). A recent large-scale study showing an unexpectedly large number of mutations in breast and colon cancer.","journal-title":"Science"},{"key":"BFnrc2091_CR16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0065-230X(08)60860-X","volume":"69","author":"N Mandahl","year":"1996","unstructured":"Mandahl, N. Cytogenetics and molecular genetics of bone and soft tissue tumors. Adv. Cancer Res. 69, 63\u201399 (1996).","journal-title":"Adv. Cancer Res."},{"key":"BFnrc2091_CR17","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1046\/j.1468-0734.2002.00069.x","volume":"6","author":"CJ Harrison","year":"2002","unstructured":"Harrison, C. J. & Foroni, L. Cytogenetics and molecular genetics of acute lymphoblastic leukemia. Rev. Clin. Exp. Hematol. 6, 91\u2013113 (2002).","journal-title":"Rev. Clin. Exp. Hematol."},{"key":"BFnrc2091_CR18","first-page":"1941","volume":"9","author":"EC Borden","year":"2003","unstructured":"Borden, E. C. et al. Soft tissue sarcomas of adults: state of the translational science. Clin. Cancer Res. 9, 1941\u20131956 (2003).","journal-title":"Clin. Cancer Res."},{"key":"BFnrc2091_CR19","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1080\/07853890410018808","volume":"36","author":"B Johansson","year":"2004","unstructured":"Johansson, B., Mertens, F. & Mitelman, F. Clinical and biological importance of cytogenetic abnormalities in childhood and adult acute lymphoblastic leukemia. Ann. Med. 36, 492\u2013503 (2004).","journal-title":"Ann. Med."},{"key":"BFnrc2091_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0268-960X(03)00040-7","volume":"18","author":"K Mr\u00f3zek","year":"2004","unstructured":"Mr\u00f3zek, K., Heerema, N. A. & Bloomfield, C. D. Cytogenetics in acute leukemia. Blood Rev. 18, 115\u2013136 (2004).","journal-title":"Blood Rev."},{"key":"BFnrc2091_CR21","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/gcc.20212","volume":"43","author":"F Mitelman","year":"2005","unstructured":"Mitelman, F., Mertens, F. & Johansson B. Prevalence estimates of recurrent balanced cytogenetic aberrations and gene fusions in unselected patients with neoplastic disorders. Genes Chromosomes Cancer 43, 350\u2013366 (2005).","journal-title":"Genes Chromosomes Cancer"},{"key":"BFnrc2091_CR22","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S1535-6108(02)00032-6","volume":"1","author":"EJ Yeoh","year":"2002","unstructured":"Yeoh, E. J. et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 1, 133\u2013143 (2002).","journal-title":"Cancer Cell"},{"key":"BFnrc2091_CR23","doi-asserted-by":"publisher","first-page":"19069","DOI":"10.1073\/pnas.0506637102","volume":"102","author":"A Andersson","year":"2005","unstructured":"Andersson, A. et al. Molecular signatures in childhood acute leukemia and their correlations to expression patterns in normal hematopoietic subpopulations. Proc. Natl Acad. Sci. USA 102, 19069\u201319074 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc2091_CR24","doi-asserted-by":"publisher","first-page":"6936","DOI":"10.1158\/0008-5472.CAN-05-4578","volume":"66","author":"E Davicioni","year":"2006","unstructured":"Davicioni, E. et al. Identification of a PAX-FKHR gene expression signature that defines molecular classes and determines the prognosis of alveolar rhabdomyosarcomas. Cancer Res. 66, 6936\u20136946 (2006).","journal-title":"Cancer Res."},{"key":"BFnrc2091_CR25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1126\/science.959840","volume":"194","author":"PC Nowell","year":"1976","unstructured":"Nowell, P. C. The clonal evolution of tumor cell populations. Science 194, 23\u201328 (1976).","journal-title":"Science"},{"key":"BFnrc2091_CR26","first-page":"5911","volume":"48","author":"S Heim","year":"1988","unstructured":"Heim, S., Mandahl, N. & Mitelman, F. Genetic convergence and divergence in tumor progression. Cancer Res. 48, 5911\u20135916 (1988).","journal-title":"Cancer Res."},{"key":"BFnrc2091_CR27","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/(SICI)1098-2264(199607)16:3<155::AID-GCC1>3.0.CO;2-Y","volume":"16","author":"B Johansson","year":"1996","unstructured":"Johansson, B., Mertens, F. & Mitelman, F. Primary vs. secondary neoplasia-associated chromosomal abnormalities \u2013 balanced rearrangements vs. genomic imbalances? Genes Chromosomes Cancer 16, 155\u2013163 (1996).","journal-title":"Genes Chromosomes Cancer"},{"key":"BFnrc2091_CR28","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S1044-579X(02)00012-3","volume":"12","author":"PC Nowell","year":"2002","unstructured":"Nowell, P. C. Tumor progression: a brief historical perspective. Semin. Cancer Biol. 12, 261\u2013266 (2002).","journal-title":"Semin. Cancer Biol."},{"key":"BFnrc2091_CR29","first-page":"64","volume":"16","author":"TS Hauschka","year":"1953","unstructured":"Hauschka, T. S. Cell population studies on mouse ascites tumors. Ann. NY Acad. Sci. 16, 64\u201373 (1953).","journal-title":"Ann. NY Acad. Sci."},{"key":"BFnrc2091_CR30","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1002\/1097-0142(195607\/08)9:4<648::AID-CNCR2820090404>3.0.CO;2-I","volume":"9","author":"A Levan","year":"1956","unstructured":"Levan, A. Chromosomal studies on some human tumors and tissues of normal origin, grown in vivo and in vitro at the Sloan-Kettering Institute. Cancer 9, 648\u2013663 (1956).","journal-title":"Cancer"},{"key":"BFnrc2091_CR31","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1111\/j.1749-6632.1956.tb50894.x","volume":"63","author":"S Makino","year":"1956","unstructured":"Makino, S. Further evidence favoring the concept of the stem cell in ascites tumors of rats. Ann. NY Acad. Sci. 63, 818\u2013830 (1956).","journal-title":"Ann. NY Acad. Sci."},{"key":"BFnrc2091_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0065-230X(08)60209-2","volume":"52","author":"S Heim","year":"1989","unstructured":"Heim, S. & Mitelman, F. Primary chromosome abnormalities in human neoplasia. Adv. Cancer Res. 52, 1\u201343 (1989).","journal-title":"Adv. Cancer Res."},{"key":"BFnrc2091_CR33","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1182\/blood.V95.3.738.003k21_738_743","volume":"95","author":"PB Sinclair","year":"2000","unstructured":"Sinclair, P. B. et al. Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia. Blood 95, 738\u2013743 (2000).","journal-title":"Blood"},{"key":"BFnrc2091_CR34","doi-asserted-by":"publisher","first-page":"3581","DOI":"10.1182\/blood.V97.11.3581","volume":"97","author":"E Kolomietz","year":"2001","unstructured":"Kolomietz, E. et al. Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis. Blood 97, 3581\u20133588 (2001).","journal-title":"Blood"},{"key":"BFnrc2091_CR35","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.tig.2005.10.002","volume":"22","author":"PD Aplan","year":"2006","unstructured":"Aplan, P. D. Causes of oncogenic chromosomal translocation. Trends Genet. 22, 46\u201355 (2006). A recent review of mechanisms behind the origin of neoplasia-associated translocations and gene fusions.","journal-title":"Trends Genet."},{"key":"BFnrc2091_CR36","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/S1471-4914(02)02384-5","volume":"8","author":"EM Rego","year":"2002","unstructured":"Rego, E. M. & Pandolfi, P. P. Reciprocal products of chromosomal translocations in human cancer pathogenesis: key players or innocent bystanders? Trends Mol. Med. 8, 396\u2013405 (2002).","journal-title":"Trends Mol. Med."},{"key":"BFnrc2091_CR37","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1016\/j.ejca.2005.08.003","volume":"41","author":"SJ Xia","year":"2005","unstructured":"Xia S. J. & Barr, F. G. Chromosome translocations in sarcomas and the emergence of oncogenic transcription factors. Eur. J. Cancer 41, 2513\u20132527 (2005).","journal-title":"Eur. J. Cancer"},{"key":"BFnrc2091_CR38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1365-2559.2005.02285.x","volume":"48","author":"CR Antonescu","year":"2006","unstructured":"Antonescu, C. R. The role of genetic testing in soft tissue sarcoma. Histopathology 48, 13\u201321 (2006).","journal-title":"Histopathology"},{"key":"BFnrc2091_CR39","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s11912-003-0030-x","volume":"5","author":"VG Oehler","year":"2003","unstructured":"Oehler, V. G. & Radich, J. P. Monitoring bcr-abl by polymerase chain reaction in the treatment of chronic myeloid leukemia. Curr. Oncol. Rep. 5, 426\u2013435 (2003).","journal-title":"Curr. Oncol. Rep."},{"key":"BFnrc2091_CR40","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1002\/cncr.20059","volume":"100","author":"S Avigad","year":"2004","unstructured":"Avigad, S. et al. The predictive potential of molecular detection in the nonmetastatic Ewing family of tumors. Cancer 100, 1053\u20131058 (2004).","journal-title":"Cancer"},{"key":"BFnrc2091_CR41","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1182\/blood-2004-08-3097","volume":"105","author":"M Deininger","year":"2005","unstructured":"Deininger, M., Buchdunger, E. & Druker, B. J. The development of imatinib as a therapeutic agent for chronic myeloid leukemia. Blood 105, 2640\u20132653 (2005). Provides an up-to-date review of targeted therapy in  BCR \u2013 ABL1 -positive leukaemia.","journal-title":"Blood"},{"key":"BFnrc2091_CR42","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.critrevonc.2004.06.004","volume":"56","author":"W Kern","year":"2005","unstructured":"Kern, W., Schoch, C., Haferlach, T. & Schnittger, S. Monitoring of minimal residual disease in acute myeloid leukemia. Crit. Rev. Oncol. Hematol. 56, 283\u2013309 (2005).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"BFnrc2091_CR43","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/318533a0","volume":"318","author":"JM Adams","year":"1985","unstructured":"Adams, J. M. et al. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318, 533\u2013538 (1985).","journal-title":"Nature"},{"key":"BFnrc2091_CR44","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1126\/science.2406902","volume":"247","author":"GQ Daley","year":"1990","unstructured":"Daley, G. Q., Van Etten, R. A. & Baltimore, D. Induction of chronic myelogenous leukemia in mice by the P210bcr\/abl gene of the Philadelphia chromosome. Science 247, 824\u2013830 (1990).","journal-title":"Science"},{"key":"BFnrc2091_CR45","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1002\/j.1460-2075.1990.tb08212.x","volume":"9","author":"AG Elefanty","year":"1990","unstructured":"Elefanty, A. G., Hariharan, I. K. & Cory, S. bcr-abl, the hallmark of chronic myeloid leukaemia in man, induces multiple haemopoietic neoplasms in mice. EMBO J. 9, 1069\u20131078 (1990).","journal-title":"EMBO J."},{"key":"BFnrc2091_CR46","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/344251a0","volume":"344","author":"N Heisterkamp","year":"1990","unstructured":"Heisterkamp, N. et al. Acute leukaemia in bcr\/abl transgenic mice. Nature 344, 251\u2013253 (1990).","journal-title":"Nature"},{"key":"BFnrc2091_CR47","first-page":"351","volume":"13","author":"MP Kamps","year":"1993","unstructured":"Kamps, M. P. & Baltimore, D. E2A-Pbx1, the t(1;19) translocation protein of human pre-B-cell acute lymphocytic leukemia, causes acute myeloid leukemia in mice. Mol. Cell Biol. 13, 351\u2013357 (1993).","journal-title":"Mol. Cell Biol."},{"key":"BFnrc2091_CR48","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S0092-8674(00)81269-6","volume":"85","author":"J Corral","year":"1996","unstructured":"Corral, J. et al. An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes. Cell 85, 853\u2013861 (1996).","journal-title":"Cell"},{"key":"BFnrc2091_CR49","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1038\/sj.onc.1203572","volume":"19","author":"J P\u00e9rez-Losada","year":"2000","unstructured":"P\u00e9rez-Losada, J. et al. The chimeric FUS\/TLS-CHOP fusion protein specifically induces liposarcomas in transgenic mice. Oncogene 19, 2413\u20132422 (2000).","journal-title":"Oncogene"},{"key":"BFnrc2091_CR50","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1038\/sj.onc.1209216","volume":"25","author":"EM Rego","year":"2006","unstructured":"Rego, E. M. et al. Leukemia with distinct phenotypes in transgenic mice expressing PML\/RAR\u03b1, PLZF\/RAR \u03b1 or NPM\/RAR \u03b1. Oncogene 25, 1974\u20131979 (2006).","journal-title":"Oncogene"},{"key":"BFnrc2091_CR51","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2174\/1568009013334214","volume":"1","author":"A Rodriguez-Garcia","year":"2001","unstructured":"Rodriguez-Garcia, A. et al. Selective destruction of tumor cells through specific inhibition of products resulting from chromosomal translocations. Curr. Cancer Drug Targets 1, 109\u2013119 (2001).","journal-title":"Curr. Cancer Drug Targets"},{"key":"BFnrc2091_CR52","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1745-7254.2006.00282.x","volume":"27","author":"M Thomas","year":"2006","unstructured":"Thomas, M., Greil, J. & Heidenreich, O. Targeting leukemic fusion proteins with small interfering RNAs: recent advances and therapeutic potentials. Acta Pharmacol. Sin. 27, 273\u2013281 (2006).","journal-title":"Acta Pharmacol. Sin."},{"key":"BFnrc2091_CR53","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrc1589","volume":"5","author":"R K\u00fcppers","year":"2005","unstructured":"K\u00fcppers, R. Mechanisms of B-cell lymphoma pathogenesis. Nature Rev. Cancer 5, 251\u2013262 (2005).","journal-title":"Nature Rev. Cancer"},{"key":"BFnrc2091_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/gcc.10202","volume":"37","author":"N Sirvent","year":"2003","unstructured":"Sirvent, N., Maire, G. & Pedeutour, F. Genetics of dermatofibrosarcoma protuberans family of tumors: from ring chromosomes to tyrosine kinase inhibitor treatment. Genes Chromosomes Cancer 37, 1\u201319 (2003).","journal-title":"Genes Chromosomes Cancer"},{"key":"BFnrc2091_CR55","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/ng0297-170","volume":"15","author":"K Kas","year":"1997","unstructured":"Kas, K. et al. Promoter swapping between the genes for a novel zinc finger protein and beta-catenin in pleiomorphic adenomas with t(3;8)(p21;q12) translocations. Nature Genet. 15, 170\u2013174 (1997). First example of a translocation resulting in gene deregulation through promoter exchange in a solid tumour.","journal-title":"Nature Genet."},{"key":"BFnrc2091_CR56","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1016\/S0002-9440(10)63723-6","volume":"164","author":"A Dahl\u00e9n","year":"2004","unstructured":"Dahl\u00e9n, A. et al. Activation of the GLI oncogene through fusion with the \u03b2-actin gene (ACTB) in a group of distinctive pericytic neoplasms: pericytoma with t(7;12). Am. J. Pathol. 164, 1645\u20131653 (2004).","journal-title":"Am. J. Pathol."},{"key":"BFnrc2091_CR57","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.1038\/sj.onc.1208506","volume":"24","author":"AM Oliveira","year":"2005","unstructured":"Oliveira, A. M. et al. Aneurysmal bone cyst variant translocations upregulate USP6 transcription by promoter swapping with the ZNF9, COL1A1, TRAP150, and OMD genes. Oncogene 24, 3419\u20133426 (2005).","journal-title":"Oncogene"},{"key":"BFnrc2091_CR58","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1073\/pnas.0507321103","volume":"103","author":"RB West","year":"2006","unstructured":"West, R. B. et al. A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells. Proc. Natl Acad. Sci. USA 103, 690\u2013695 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc2091_CR59","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/gcc.10107","volume":"35","author":"C Popovici","year":"2002","unstructured":"Popovici, C. et al. Reciprocal translocations in breast tumor cell lines: cloning of a t(3;20) that targets the FHIT gene. Genes Chromosomes Cancer 35, 204\u2013218 (2002).","journal-title":"Genes Chromosomes Cancer"},{"key":"BFnrc2091_CR60","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/gcc.20081","volume":"41","author":"E Belloni","year":"2004","unstructured":"Belloni, E. et al. A new complex rearrangement involving the ETV6, LOC115548, and MN1 genes in a case of acute myeloid leukemia. Genes Chromosomes Cancer 41, 272\u2013277 (2004).","journal-title":"Genes Chromosomes Cancer"},{"key":"BFnrc2091_CR61","doi-asserted-by":"publisher","first-page":"8101","DOI":"10.1158\/0008-5472.CAN-04-0366","volume":"65","author":"L Karenko","year":"2005","unstructured":"Karenko, L. et al. Primary cutaneous T-cell lymphomas show a deletion or translocation affecting NAV3, the human UNC-53 homologue. Cancer Res. 65, 8101\u20138110 (2005).","journal-title":"Cancer Res."},{"key":"BFnrc2091_CR62","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/sj.leu.2404063","volume":"20","author":"R Berger","year":"2006","unstructured":"Berger, R. et al. Loss of the NPM1 gene in myeloid disorders with chromosome 5 rearrangements. Leukemia 20, 319\u2013321 (2006).","journal-title":"Leukemia"},{"key":"BFnrc2091_CR63","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1111\/j.1365-2141.2006.06020.x","volume":"133","author":"I Panagopoulos","year":"2006","unstructured":"Panagopoulos, I. et al. Fusion of ETV6 with an intronic sequence of the BAZ2A gene in a paediatric pre-B acute lymphoblastic leukaemia with a cryptic chromosome 12 rearrangement. Br. J. Haematol. 133, 270\u2013275 (2006).","journal-title":"Br. J. Haematol."},{"key":"BFnrc2091_CR64","doi-asserted-by":"publisher","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","volume":"96","author":"MWN Deininger","year":"2000","unstructured":"Deininger, M. W. N., Goldman, J. M. & Melo, J. V. The molecular biology of chronic myeloid leukemia. Blood 96, 3343\u20133356 (2000).","journal-title":"Blood"},{"key":"BFnrc2091_CR65","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/ng1335","volume":"36","author":"F Mitelman","year":"2004","unstructured":"Mitelman, F., Johansson, B. & Mertens, F. Fusion genes and rearranged genes as a linear function of chromosome aberrations in cancer. Nature Genet. 36, 331\u2013334 (2004). An analysis of the impact of cytogenetic analyses on the detection of new gene fusions.","journal-title":"Nature Genet."},{"key":"BFnrc2091_CR66","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.semcancer.2005.01.003","volume":"15","author":"CL Lannon","year":"2005","unstructured":"Lannon, C. L. & Sorensen, P. H. B. ETV6-NTRK3: a chimeric protein tyrosine kinase with transformation activity in multiple cell lineages. Semin. Cancer Biol. 15, 215\u2013223 (2005). A review of the pathogenetic implications of a gene fusion involved in histogenetically distinct tumour types.","journal-title":"Semin. Cancer Biol."},{"key":"BFnrc2091_CR67","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/sj.leu.2404150","volume":"20","author":"C Meyer","year":"2006","unstructured":"Meyer, C. et al. The MLL recombinome of acute leukemias. Leukemia 20, 777\u2013784 (2006). A recent summary of partner genes involved in fusions with the  MLL  gene.","journal-title":"Leukemia"},{"key":"BFnrc2091_CR68","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.semcancer.2005.01.008","volume":"15","author":"SK Bohlander","year":"2005","unstructured":"Bohlander, S. K. ETV6: a versatile player in leukemogenesis. Semin. Cancer Biol. 15, 162\u2013174 (2005).","journal-title":"Semin. Cancer Biol."},{"key":"BFnrc2091_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2005.08.007","volume":"363","author":"R Janknecht","year":"2005","unstructured":"Janknecht, R. EWS-ETS oncoproteins: the linchpin of Ewing tumors. Gene 363, 1\u201314 (2005).","journal-title":"Gene"},{"key":"BFnrc2091_CR70","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1038\/sj.onc.1209290","volume":"25","author":"M H\u00f6glund","year":"2006","unstructured":"H\u00f6glund, M., Frigyesi, A. & Mitelman, F. A gene fusion network in human neoplasia. Oncogene 25, 2674\u20132678 (2006).","journal-title":"Oncogene"},{"key":"BFnrc2091_CR71","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrg1272","volume":"5","author":"A-L Barab\u00e1si","year":"2004","unstructured":"Barab\u00e1si, A.-L. & Oltvai, Z. N. Network biology: understanding the cell's functional organization. Nature Rev. Genet. 5, 101\u2013113 (2004).","journal-title":"Nature Rev. Genet."},{"key":"BFnrc2091_CR72","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/sj.onc.1204074","volume":"20","author":"M Ladanyi","year":"2001","unstructured":"Ladanyi, M. et al. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene 20, 48\u201357 (2001).","journal-title":"Oncogene"},{"key":"BFnrc2091_CR73","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/ng1425","volume":"36","author":"C Graux","year":"2004","unstructured":"Graux, C. et al. Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia. Nature Genet. 36, 1084\u20131089 (2004).","journal-title":"Nature Genet."},{"key":"BFnrc2091_CR74","first-page":"1477","volume":"6","author":"O Bernard","year":"1991","unstructured":"Bernard, O. et al. Two site-specific deletions and t(1;14) translocation restricted to human T-cell acute leukemias disrupt the 5' part of the tal-1 gene. Oncogene 6, 1477\u20131488 (1991).","journal-title":"Oncogene"},{"key":"BFnrc2091_CR75","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1073\/pnas.040569197","volume":"97","author":"PJ Kourlas","year":"2000","unstructured":"Kourlas, P. J. et al. Identification of a gene at 11q23 encoding a guanine nucleotide exchange factor: evidence for its fusion with MLL in acute myeloid leukemia. Proc. Natl Acad. Sci. USA 97, 2145\u20132150 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc2091_CR76","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/gcc.10204","volume":"37","author":"J-F Fu","year":"2003","unstructured":"Fu J.-F., Hsu J.-J., Tang T.-C. & Shih L.-Y. Identification of CBL, a proto-oncogene at 11q23. 3, as a novel MLL fusion partner in a patient with de novo acute myeloid leukemia. Genes Chromosomes Cancer 37, 214\u2013219 (2003).","journal-title":"Genes Chromosomes Cancer"},{"key":"BFnrc2091_CR77","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1073\/pnas.0406994102","volume":"102","author":"C Meyer","year":"2005","unstructured":"Meyer, C. et al. Diagnostic tool for the identification of MLL rearrangements including unknown partner genes. Proc. Natl Acad. Sci. USA 102, 449\u2013454 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc2091_CR78","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1182\/blood-2003-05-1627","volume":"102","author":"A Pardanani","year":"2003","unstructured":"Pardanani, A. et al. CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy. Blood 102, 3093\u20133096 (2003).","journal-title":"Blood"},{"key":"BFnrc2091_CR79","first-page":"4869","volume":"60","author":"MK Hibbard","year":"2000","unstructured":"Hibbard, M. K. et al. PLAG1 fusion oncogenes in lipoblastoma. Cancer Res. 60, 4869\u20134872 (2000).","journal-title":"Cancer Res."},{"key":"BFnrc2091_CR80","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/gcc.10207","volume":"37","author":"A Charest","year":"2003","unstructured":"Charest, A. et al. Fusion of FIG to the receptor tyrosine kinase ROS in a glioblastoma with an interstitial del(6)(q21q21). Genes Chromosomes Cancer 37, 58\u201371 (2003).","journal-title":"Genes Chromosomes Cancer"},{"key":"BFnrc2091_CR81","doi-asserted-by":"publisher","first-page":"8337","DOI":"10.1158\/0008-5472.CAN-06-1482","volume":"66","author":"S Perner","year":"2006","unstructured":"Perner, S. et al. TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer. Cancer Res. 66, 8337\u20138341 (2006).","journal-title":"Cancer Res."},{"key":"BFnrc2091_CR82","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1593\/neo.06283","volume":"8","author":"M Yoshimoto","year":"2006","unstructured":"Yoshimoto, M. et al. Three-color FISH analysis of TMPRSS2\/ERG fusions in prostate cancer indicates that genomic microdeletion of chromosome 21 is associated with rearrangement. Neoplasia 8, 465\u2013469 (2006).","journal-title":"Neoplasia"},{"key":"BFnrc2091_CR83","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/ng0497supp-417","volume":"15","author":"F Mitelman","year":"1997","unstructured":"Mitelman, F., Mertens, F. & Johansson, B. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nature Genet. 15, 417\u2013474 (1997).","journal-title":"Nature Genet."},{"key":"BFnrc2091_CR84","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/2524","volume":"20","author":"D Pinkel","year":"1998","unstructured":"Pinkel, D. et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nature Genet. 20, 207\u2013211 (1998).","journal-title":"Nature Genet."},{"key":"BFnrc2091_CR85","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/12640","volume":"23","author":"JR Pollack","year":"1999","unstructured":"Pollack, J. R. et al. Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Natrue Genet. 23, 41\u201346 (1999).","journal-title":"Natrue Genet."},{"key":"BFnrc2091_CR86","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0065-230X(03)90003-0","volume":"90","author":"JK Cowell","year":"2003","unstructured":"Cowell, J. K. & Nowak, N. J. High-resolution analysis of genetic events in cancer cells using bacterial artificial chromosome arrays and comparative genome hybridization. Adv. Cancer Res. 90, 91\u2013125 (2003).","journal-title":"Adv. Cancer Res."},{"key":"BFnrc2091_CR87","first-page":"1502","volume":"90","author":"U Bacher","year":"2005","unstructured":"Bacher, U. et al. Population-based age-specific incidences of cytogenetic subgroups of acute myeloid leukemia. Haematologica 90, 1502\u20131510 (2005).","journal-title":"Haematologica"},{"key":"BFnrc2091_CR88","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/sj.leu.2404055","volume":"20","author":"RN Sanderson","year":"2006","unstructured":"Sanderson R. N. et al. Population-based demographic study of karyotypes in 1709 patients with adult acute myeloid leukemia. Leukemia 20, 444\u2013450 (2006).","journal-title":"Leukemia"},{"key":"BFnrc2091_CR89","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/(SICI)1098-2264(199810)23:2<81::AID-GCC1>3.0.CO;2-0","volume":"23","author":"L Gorunova","year":"1998","unstructured":"Gorunova, L. et al. Cytogenetic analysis of pancreatic carcinomas: intratumor heterogeneity and nonrandom pattern of chromosome aberrations. Genes Chromosomes Cancer 23, 81\u201399 (1998).","journal-title":"Genes Chromosomes Cancer"},{"key":"BFnrc2091_CR90","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/(SICI)1098-2264(199903)24:3<222::AID-GCC7>3.0.CO;2-A","volume":"24","author":"B Johansson","year":"1999","unstructured":"Johansson, B. et al. Cytogenetic polyclonality in hematologic malignancies. Genes Chromosomes Cancer 24, 222\u2013229 (1999).","journal-title":"Genes Chromosomes Cancer"},{"key":"BFnrc2091_CR91","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.cancergencyto.2005.07.013","volume":"164","author":"JY Han","year":"2006","unstructured":"Han, J. Y., Theil, K. S. & Hoeltge, G. Frequencies and characterization of cytogenetically unrelated clones in various hematologic malignancies: seven years of experiences in a single institution. Cancer Genet. Cytogenet. 164, 128\u2013132 (2006).","journal-title":"Cancer Genet. Cytogenet."},{"key":"BFnrc2091_CR92","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1073\/pnas.89.5.1616","volume":"89","author":"MA Pierotti","year":"1992","unstructured":"Pierotti, M. A. et al. Characterization of an inversion on the long arm of chromosome 10 juxtaposing D10S170 and RET and creating the oncogenic sequence RET\/PTC. Proc. Natl Acad. Sci. USA 89, 1616\u20131620 (1992). The first description of a gene fusion in a solid tumour.","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc2091_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0304-3835(01)00439-6","volume":"166","author":"MA Pierotti","year":"2001","unstructured":"Pierotti, M. A. Chromosomal rearrangements in thyroid carcinomas: a recombination or death dilemma. Cancer Lett. 166, 1\u20137 (2001).","journal-title":"Cancer Lett."},{"key":"BFnrc2091_CR94","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/gcc.20306","volume":"45","author":"A Behboudi","year":"2006","unstructured":"Behboudi, A. et al. Molecular classification of mucoepidermoid carcinomas- prognostic significance of the MECT1-MAML2 fusion oncogene. Genes Chromosomes Cancer 45, 470\u2013481 (2006).","journal-title":"Genes Chromosomes Cancer"},{"key":"BFnrc2091_CR95","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1200\/JCO.2004.02.107","volume":"22","author":"CA French","year":"2004","unstructured":"French, C. A. et al. Midline carcinoma of children and young adults with NUT rearrangement. J. Clin. Oncol. 22, 4135\u20134139 (2004).","journal-title":"J. Clin. Oncol."},{"key":"BFnrc2091_CR96","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1126\/science.1117679","volume":"310","author":"SA Tomlins","year":"2005","unstructured":"Tomlins, S. A. et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310, 644\u2013648 (2005). The first study to show a fusion gene that occurs in a large proportion of a common malignant solid tumour.","journal-title":"Scienc"},{"key":"BFnrc2091_CR97","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1593\/neo.06427","volume":"8","author":"N Cerveira","year":"2006","unstructured":"Cerveira, N. et al. TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions. Neoplasia 8, 826\u2013832 (2006).","journal-title":"Neoplasia"},{"key":"BFnrc2091_CR98","doi-asserted-by":"publisher","first-page":"10658","DOI":"10.1158\/0008-5472.CAN-06-1871","volume":"66","author":"KG Hermans","year":"2006","unstructured":"Hermans, K. G. et al. TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer. Cancer Res. 66, 10658\u201310663 (2006).","journal-title":"Cancer Res."},{"key":"BFnrc2091_CR99","doi-asserted-by":"publisher","first-page":"10242","DOI":"10.1158\/0008-5472.CAN-06-1986","volume":"66","author":"K Iljin","year":"2006","unstructured":"Iljin, K. et al. TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming. Cancer Res. 66, 10242\u201310246 (2006).","journal-title":"Cancer Res."},{"key":"BFnrc2091_CR100","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/gcc.20329","volume":"45","author":"MJ Soller","year":"2006","unstructured":"Soller, M. J. et al. Confirmation of the high frequency of the TMPRSS2\/ERG fusion gene in prostate cancer. Genes Chromosomes Cancer 45, 717\u2013719 (2006).","journal-title":"Genes Chromosomes Cancer"},{"key":"BFnrc2091_CR101","doi-asserted-by":"publisher","first-page":"8347","DOI":"10.1158\/0008-5472.CAN-06-1966","volume":"66","author":"J Wang","year":"2006","unstructured":"Wang, J., Cai, Y., Ren, C. & Ittmann, M. Expression of variant TMPRSS2\/ERG fusion messenger RNAs is associated with aggressive prostate cancer. Cancer Res. 66, 8347\u20138351 (2006).","journal-title":"Cancer Res."},{"key":"BFnrc2091_CR102","doi-asserted-by":"publisher","first-page":"3396","DOI":"10.1158\/0008-5472.CAN-06-0168","volume":"66","author":"SA Tomlins","year":"2006","unstructured":"Tomlins, S. A. et al. TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer. Cancer Res. 66, 3396\u20133400 (2006).","journal-title":"Cancer Res."},{"key":"BFnrc2091_CR103","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","volume":"55","author":"DM Parkin","year":"2005","unstructured":"Parkin, D. M., Bray, F., Ferlay, J. & Pisani, P. Global cancer statistics, 2002. CA. Cancer J. Clin. 55, 74\u2013108 (2005).","journal-title":"CA. Cancer J. Clin."},{"key":"BFnrc2091_CR104","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1200\/JCO.2005.05.2308","volume":"24","author":"F Kamanger","year":"2006","unstructured":"Kamanger, F., Dores, G. M. & Anderson, W. F. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J. Clin. Oncol. 24, 2137\u20132150 (2006).","journal-title":"J. Clin. Oncol."},{"key":"BFnrc2091_CR105","unstructured":"Cancer Incidence in Sweden 2004. The National Board of Health and Welfare, Stockholm (2004)."},{"key":"BFnrc2091_CR106","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.tig.2006.02.001","volume":"22","author":"FJ Novo","year":"2006","unstructured":"Novo, F. J. & Vizmanos, J. L. Chromosome translocations in cancer: computational evidence for the random generation of double-strand breaks. Trends Genet. 22, 193\u2013196 (2006).","journal-title":"Trends Genet."},{"key":"BFnrc2091_CR107","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.dnarep.2006.05.016","volume":"5","author":"LF Povirk","year":"2006","unstructured":"Povirk, L. F. Biochemical mechanisms of chromosomal translocations resulting from DNA double-strand breaks. DNA Repair 5, 1199\u20131212 (2006).","journal-title":"DNA Repair"},{"key":"BFnrc2091_CR108","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0027-5107(02)00076-3","volume":"504","author":"G Obe","year":"2002","unstructured":"Obe, G. et al. Chromosomal aberrations: formation, identification and distribution. Mutat. Res. 504, 17\u201336 (2002).","journal-title":"Mutat. Res."},{"key":"BFnrc2091_CR109","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1126\/science.176.4041.1340","volume":"176","author":"F Mitelman","year":"1972","unstructured":"Mitelman, F., Mark, J., Levan, G. & Levan, A. Tumor etiology and chromosome pattern. Science 176, 1340\u20131341 (1972).","journal-title":"Science"},{"key":"BFnrc2091_CR110","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1182\/blood.V52.6.1229.1229","volume":"52","author":"F Mitelman","year":"1978","unstructured":"Mitelman, F., Brandt, L. & Nilsson, P. G. Relation among occupational exposure to potential mutagenic\/carcinogenic agents, clinical findings, and bone marrow chromosomes in acute nonlymphocytic leukemia. Blood 52, 1229\u20131237 (1978).","journal-title":"Blood"},{"key":"BFnrc2091_CR111","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1038\/sj.leu.2402713","volume":"16","author":"N Mauritzson","year":"2002","unstructured":"Mauritzson, N. et al. Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976\u20131993 and on 5098 unselected cases reported in the literature 1974\u20132001. Leukemia 16, 2366\u20132378 (2002).","journal-title":"Leukemia"},{"key":"BFnrc2091_CR112","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1182\/blood.V99.6.1909","volume":"99","author":"J Pedersen-Bjergaard","year":"2002","unstructured":"Pedersen-Bjergaard, J., Andersen, M. K., Christiansen, D. H. & Nerlov, C. Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia. Blood 99, 1909\u20131912 (2002).","journal-title":"Blood"},{"key":"BFnrc2091_CR113","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1056\/NEJMoa042715","volume":"352","author":"AR Mistry","year":"2005","unstructured":"Mistry, A. R. et al. DNA topoisomerase II in therapy-related acute promyelocytic leukemia. N. Engl. J. Med. 352, 1529\u20131538 (2005).","journal-title":"N. Engl. J. Med."},{"key":"BFnrc2091_CR114","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.dnarep.2006.05.020","volume":"5","author":"Y Zhang","year":"2006","unstructured":"Zhang, Y. & Rowley, J. D. Chromatin structural elements and chromosomal translocations in leukemia. DNA Repair 5, 1282\u20131297 (2006).","journal-title":"DNA Repair"},{"key":"BFnrc2091_CR115","first-page":"5617","volume":"55","author":"L Fugazzola","year":"1995","unstructured":"Fugazzola, L. et al. Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident. Cancer Res. 55, 5617\u20135620 (1995).","journal-title":"Cancer Res."},{"key":"BFnrc2091_CR116","first-page":"1093","volume":"6","author":"HM Rabes","year":"2000","unstructured":"Rabes, H. M. et al. Pattern of radiation-induced RET and NTRK1 rearrangements in 191 post-chernobyl papillary thyroid carcinomas: biological, phenotypic, and clinical implications. Clin. Cancer Res. 6, 1093\u20131103 (2000).","journal-title":"Clin. Cancer Res."},{"key":"BFnrc2091_CR117","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1053\/beha.2001.0158","volume":"14","author":"AM Taylor","year":"2001","unstructured":"Taylor, A. M. Chromosome instability syndromes. Best Pract. Res. Clin. Haematol. 14, 631\u2013644 (2001).","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"BFnrc2091_CR118","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/bies.20226","volume":"27","author":"T Misteli","year":"2005","unstructured":"Misteli, T. Concepts in nuclear architecture. BioEssays 27, 477\u2013487 (2005).","journal-title":"BioEssays"},{"key":"BFnrc2091_CR119","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ceb.2006.04.007","volume":"18","author":"T Cremer","year":"2006","unstructured":"Cremer, T. et al. Chromosome territories \u2013 a functional nuclear landscape. Curr. Opin. Cell Biol. 18, 307\u2013316 (2006). References 118\u2013119 provide comprehensive reviews of chromosome territories in interphase nuclei.","journal-title":"Curr. Opin. Cell Biol."},{"key":"BFnrc2091_CR120","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s004120050394","volume":"108","author":"S Kozubek","year":"1999","unstructured":"Kozubek, S. et al. The topological organization of chromosomes 9 and 22 in cell nuclei has a determinative role in the induction of t(9,22) translocations and in the pathogenesis of t(9,22) leukemias. Chromosoma 108, 426\u2013435 (1999).","journal-title":"Chromosoma"},{"key":"BFnrc2091_CR121","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1182\/blood.V93.4.1197","volume":"93","author":"H Neves","year":"1999","unstructured":"Neves, H., Ramos, C., da Silva, M. G., Parreira, A. & Parreira, L. The nuclear topography of ABL, BCR, PML, and RARalpha genes: evidence for gene proximity in specific phases of the cell cycle and stages of hematopoietic differentiation. Blood 93, 1197\u20131207 (1999).","journal-title":"Blood"},{"key":"BFnrc2091_CR122","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1126\/science.290.5489.138","volume":"290","author":"MN Nikiforova","year":"2000","unstructured":"Nikiforova, M. N. et al. Proximity of chromosomal loci that participate in radiation-induced rearrangements in human cells. Science 290, 138\u2013141 (2000).","journal-title":"Science"},{"key":"BFnrc2091_CR123","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/ng1177","volume":"34","author":"JJ Roix","year":"2003","unstructured":"Roix, J. J., McQueen, P. G., Munson, P. J., Parada, L. A. & Misteli, T. Spatial proximity of translocation-prone gene loci in human lymphomas. Nature Genet. 34, 287\u2013291 (2003).","journal-title":"Nature Genet."},{"key":"BFnrc2091_CR124","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1002\/bies.20353","volume":"28","author":"SC Raghavan","year":"2006","unstructured":"Raghavan, S. C. & Lieber, M. R. DNA structures at chromosomal translocation sites. BioEssays 28, 480\u2013494 (2006).","journal-title":"BioEssays"},{"key":"BFnrc2091_CR125","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nrc1164","volume":"3","author":"MF Greaves","year":"2003","unstructured":"Greaves, M. F. & Wiemels, J. Origins of chromosome translocations in childhood leukaemia. Nature Rev. Cancer 3, 639\u2013649 (2003). Discusses the prenatal origin of gene fusions and the latency period in the development of leukaemia.","journal-title":"Nature Rev. Cancer"},{"key":"BFnrc2091_CR126","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nrc1592","volume":"5","author":"BJP Huntly","year":"2005","unstructured":"Huntly, B. J. P. & Gilliland, D. G. Leukaemia stem cells and the evolution of cancer-stem-cell research. Nature Rev. Cancer 5, 311\u2013321 (2005).","journal-title":"Nature Rev. Cancer"},{"key":"BFnrc2091_CR127","doi-asserted-by":"crossref","unstructured":"Wang, J. C. Y. & Dick, J. E. Cancer stem cells: lessons from leukemia. Trends Cell Biol. 15, 494\u2013501 (2005). References 126\u2013127 provide comprehensive reviews of the role of stem cells in oncogenesis.","DOI":"10.1016\/j.tcb.2005.07.004"},{"key":"BFnrc2091_CR128","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1073\/pnas.0530291100","volume":"100","author":"M Al-Hajj","year":"2003","unstructured":"Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J. & Clarke, M. F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl Acad. Sci. USA 100, 3983\u20133988 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc2091_CR129","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nature03128","volume":"432","author":"SK Singh","year":"2004","unstructured":"Singh, S. K. et al. Identification of human brain tumour initiating cells. Nature 432, 396\u2013401 (2004).","journal-title":"Nature"},{"key":"BFnrc2091_CR130","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.cell.2005.03.032","volume":"121","author":"CF Bender Kim","year":"2005","unstructured":"Bender Kim, C. F. et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121, 823\u2013835 (2005).","journal-title":"Cell"},{"key":"BFnrc2091_CR131","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nature05372","volume":"445","author":"CA O'Brien","year":"2007","unstructured":"O'Brien, C. A., Pollett, A., Gallinger, S. & Dick, J. E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445, 106\u2013110 (2007).","journal-title":"Nature"},{"key":"BFnrc2091_CR132","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nature05384","volume":"445","author":"L Ricci-Vitiani","year":"2007","unstructured":"Ricci-Vitiani, L. et al. Identification and expansion of human colon-cancer-initiating cells. Nature 445, 111\u2013115 (2007).","journal-title":"Nature"},{"key":"BFnrc2091_CR133","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1159\/000046636","volume":"107","author":"B Johansson","year":"2002","unstructured":"Johansson, B., Fioretos, T. & Mitelman, F. Cytogenetic and molecular genetic evolution of chronic myeloid leukemia. Acta Haematol. 107, 76\u201394 (2002).","journal-title":"Acta Haematol."},{"key":"BFnrc2091_CR134","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1182\/blood.V85.8.2154.bloodjournal8582154","volume":"85","author":"AG Turhan","year":"1995","unstructured":"Turhan, A. G. et al. Highly purified primitive hematopoietic stem cells are PML-RARA negative and generate nonclonal progenitors in acute promyelocytic leukemia. Blood 85, 2154\u20132161 (1995).","journal-title":"Blood"},{"key":"BFnrc2091_CR135","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/nm1253","volume":"11","author":"A Castor","year":"2005","unstructured":"Castor, A. et al. Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia. Nature Med. 11, 630\u2013637 (2005).","journal-title":"Nature Med."},{"key":"BFnrc2091_CR136","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1158\/0008-5472.CAN-04-1356","volume":"65","author":"M Hotfilder","year":"2005","unstructured":"Hotfilder, M. et al. Leukemic stem cells in childhood high-risk ALL\/t(9;22) and t(4;11) are present in primitive lymphoid-restricted CD34+CD19- cells. Cancer Res. 65, 1442\u20131449 (2005).","journal-title":"Cancer Res."},{"key":"BFnrc2091_CR137","doi-asserted-by":"publisher","first-page":"11459","DOI":"10.1158\/0008-5472.CAN-05-1696","volume":"65","author":"N Riggi","year":"2005","unstructured":"Riggi, N. et al. Development of Ewing's sarcoma from primary bone marrow-derived mesenchymal progenitor cells. Cancer Res. 65, 11459\u201311468 (2005).","journal-title":"Cancer Res."},{"key":"BFnrc2091_CR138","doi-asserted-by":"publisher","first-page":"7016","DOI":"10.1158\/0008-5472.CAN-05-3979","volume":"66","author":"N Riggi","year":"2006","unstructured":"Riggi, N. et al. Expression of the FUS-CHOP fusion protein in primary mesenchymal progenitor cells gives rise to a model of myxoid liposarcoma. Cancer Res. 66, 7016\u20137023 (2006).","journal-title":"Cancer Res."},{"key":"BFnrc2091_CR139","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/gcc.10178","volume":"36","author":"S Janz","year":"2003","unstructured":"Janz, S., Potter, M. & Rabkin, C. S. Lymphoma- and leukemia-associated chromosomal translocations in healthy individuals. Genes Chromosomes Cancer 36, 211\u2013223 (2003).","journal-title":"Genes Chromosomes Cancer"},{"key":"BFnrc2091_CR140","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1182\/blood.V82.3.712.712","volume":"82","author":"G Nucifora","year":"1993","unstructured":"Nucifora, G., Larson, R. A. & Rowley, J. D. Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission. Blood 82, 712\u2013715 (1993).","journal-title":"Blood"},{"key":"BFnrc2091_CR141","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1182\/blood.V88.6.2183.bloodjournal8862183","volume":"88","author":"J Jurlander","year":"1996","unstructured":"Jurlander, J. et al. Persistence of the AML1\/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemia. Blood 88, 2183\u20132191 (1996).","journal-title":"Blood"},{"key":"BFnrc2091_CR142","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/13776","volume":"23","author":"LH Castilla","year":"1999","unstructured":"Castilla, L. H. et al. The fusion gene Cbfb-MYH11 blocks myeloid differentiation and predisposes mice to acute myelomonocytic leukaemia. Nature Genet. 23, 144\u2013146 (1999).","journal-title":"Nature Genet."},{"key":"BFnrc2091_CR143","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S1535-6108(02)00016-8","volume":"1","author":"M Higuchi","year":"2002","unstructured":"Higuchi, M. et al. Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia. Cancer Cell 1, 63\u201374 (2002).","journal-title":"Cancer Cell"},{"key":"BFnrc2091_CR144","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1146\/annurev.genom.3.032802.115046","volume":"3","author":"LM Kelly","year":"2002","unstructured":"Kelly, L. M., Gilliland, D. G. Genetics of myeloid leukemias. Annu. Rev. Genomics Hum. Genet. 3, 179\u2013198 (2002).","journal-title":"Annu. Rev. Genomics Hum. Genet."}],"container-title":["Nature Reviews Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nrc2091.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrc2091","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrc2091.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T09:06:21Z","timestamp":1650099981000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrc2091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,15]]},"references-count":144,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["BFnrc2091"],"URL":"https:\/\/doi.org\/10.1038\/nrc2091","relation":{},"ISSN":["1474-175X","1474-1768"],"issn-type":[{"value":"1474-175X","type":"print"},{"value":"1474-1768","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3,15]]},"assertion":[{"value":"15 March 2007","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}